Age-linked variation noted in melanoma management

August 15, 2013
Age-linked variation noted in melanoma management
Age-related variation is seen in the characteristics and management of melanoma, according to a study published online Aug. 14 in JAMA Dermatology.

(HealthDay)—Age-related variation is seen in the characteristics and management of melanoma, according to a study published online Aug. 14 in JAMA Dermatology.

Dragos Ciocan, M.D., from the Hôpital Robert Debré in Reims, France, and colleagues conducted a retrospective population-based study involving 1,621 incident cases of primary stage I or II in 2004 and 2008 to identify characteristics of melanoma and its management in elderly versus younger patients. The cohort included 487 patients aged 70 years or older and 1,134 patients aged younger than 70 years.

The researchers found that older patients had melanomas of the head and neck significantly more frequently (29.4 versus 8.7 percent), and histologic subtypes were more often nodular, lentigo maligna, or acral lentiginous. Compared with younger patients, older patients had thicker and more frequently ulcerated tumors, which were categorized as T3 or T4 in 36.7 and 20.1 percent of cases, respectively. Melanoma diagnosis was more frequent in general practice settings and less common in direct consultation with a or during a routine screening. For older patients, time to excision was longer, and insufficient excision margins were noted in 16.8 percent, compared to 5.0 percent in younger patients. Sentinel lymph node biopsy was performed in significantly fewer older versus younger patients with melanoma thicker than 1 mm (23.3 versus 41.4 percent). In older patients, adjuvant therapy was started less frequently and was stopped prematurely in a greater proportion of patients.

"Age-related variations are observed at every step of melanoma management," the authors write. "The most important concerns are access of elderly people to settings for early diagnosis and excision with appropriate margins."

Explore further: Risk of second primary melanoma up in pediatric patients

More information: Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Related Stories

Risk of second primary melanoma up in pediatric patients

June 28, 2012

(HealthDay) -- Pediatric patients diagnosed with an invasive cutaneous melanoma have nearly double the relative risk of developing a subsequent primary melanoma, compared with adults, according to a study published online ...

AAD: Older men should screen themselves for skin cancer

March 1, 2013

(HealthDay)—Men aged 50 years or older are more likely to be diagnosed with invasive melanoma by a dermatologist than to detect it themselves; and they are less likely to seek a skin cancer screening due to a suspicious ...

Mortality similar for single and multiple primary melanomas

June 24, 2013

(HealthDay)—Mortality is similar for patients with single primary melanomas (SPMs) and multiple primary melanomas (MPMs), but relative mortality is considerably higher for patients with thicker SPMs versus thicker MPMs, ...

Many children with melanoma do not meet ABCDE criteria

July 19, 2013

(HealthDay)—A considerable proportion of children with melanoma do not present with conventional melanoma detection criteria (asymmetry, border irregularity, color variegation, diameter >6 mm, and evolution [ABCDE]), according ...

Nonsentinel lymph nodes key factor in melanoma prognosis

August 2, 2013

(HealthDay)—Nonsentinel lymph node (NSLN) positivity is a significant prognostic factor in patients with stage III melanoma, associated with shorter overall and disease-specific survival, according to research published ...

Recommended for you

Combination therapy can prevent cytostatic resistance

November 26, 2015

Researchers at Karolinska Institutet have found a new way of preventing resistance to cytostatics used in the treatment of cancers such as medulloblastoma, the most common form of malignant brain tumour in children. The promising ...

Forecasting the path of breast cancer in a patient

November 23, 2015

USC researchers have developed a mathematical model to forecast metastatic breast cancer survival rates using techniques usually reserved for weather prediction, financial forecasting and surfing the Web.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.